Will I be able to work after bladder cancer treatment at 57?

Hello,

Welcome to icliniq.com.

I read your query and can understand your concern.

Bladder cancer significantly impacts your lifestyle, leading to physical and emotional challenges. You may experience fatigue, urinary issues, or other side effects from treatment, but many can adapt and continue working, often with accommodations.

Bladder cancer treatment, whether surgery, chemotherapy, or both, can impact your ability to care for your family, but it is important to understand the potential challenges and how to manage them. The extent of the impact depends on factors like the stage of your cancer, the treatment plan, and your overall condition.

Based on the staging and types of your cancer, there are different clinical trials that focus on different pathways of cancer treatment. These research based trails include immunotherapy, new drug combinations, and targeted therapies. Trials explore these approaches, including combination treatments like Enfortumab vedotin (an antibody-drug conjugate) and Pembrolizumab (a PD-1 inhibitor), and studies on the effectiveness of specific fibroblast growth factor receptor (FGFR) inhibitors like Erdafitinib.

Clinical trials you can consider:

• Trials of drugs like Pembrolizumab and Durvalumab are investigating the role of immunotherapy in treating bladder cancer, including muscle-invasive and non-muscle-invasive forms.
• Researchers are exploring the efficacy of combining existing drugs, like Enfortumab vedotin and Pembrolizumab, to enhance treatment outcomes.
• Doctors are evaluating the effectiveness of targeted therapies, such as Erdafitinib, for specific gene mutations (like fibroblast growth factor receptor) in advanced bladder cancer.
• Trials have shown that Bacillus Calmette-Guérin (BCG, a weakened strain of Mycobacterium bovis) can be used in the treatment of non-muscle-invasive bladder cancer, including different strains of BCG and combinations with vaccination.
• Research is ongoing to determine if circulating tumor DNA (ctDNA) measurement in the blood can help identify patients who may benefit from additional treatment after surgery.

However, before considering clinical trials, you must go through the details of the trials and their approvals. Also, knowing the risk factors related to such trials is important for you.

I hope this information helps you.

Feel free to ask further queries.

Thank you.